L-glutamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on serum creatine kinase activity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Consistent with muscle mass, markers of myofibrillar protein breakdown (3 methyl-histidine/creatinine ratio in urine) and serum CPK were not affected by Gln treatment compared with placebo (Table 2).”
Quoted verbatim from Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.. - Study
- crossover
- Dose
- 0.5 g/kg/d oral glutamine once daily for 4 months versus maltodextrin placebo of equal weight, 1-month washout
- Population
- 30 ambulant boys aged 2 to 10 years with Duchenne muscular dystrophy, 5 on corticosteroids; change over the 4-month glutamine phase versus the 4-month placebo phase
Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.2009PMID:19421321Permalink
Keep reading
- Everything the graph holds on L-glutamine
- Every compound studied against Serum creatine kinase activity
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45SN8KG9K6P5ZNKGGRQAHJT